Search

Your search keyword '"Jinnouchi, Mikako"' showing total 18 results
Start Over Author "Jinnouchi, Mikako"
18 results on '"Jinnouchi, Mikako"'

6. Rapidly Destructive Coxarthrosis as a Potential Side Effect of Crizotinib in a Patient with ROS1-Positive Lung Adenocarcinoma

Author

Takamori, Shinkichi, Seto, Takashi, Jinnouchi, Mikako, Oba, Taro, Yamaguchi, Masafumi, and Takenoyama, Mitsuhiro

Subjects
crizotinib, rapidly destructive coxarthrosis, Case Report, ROS1, non-small cell lung cancer
Abstract

A 75-year-old woman was diagnosed with c-ros oncogene 1 (ROS1)-positive lung adenocarcinoma. She was treated with crizotinib 750 mg/day for 4.5 years, with partial tumor response. However, the patient subsequently presented with right hip pain and difficulty in walking. She underwent magnetic resonance imaging (MRI), which detected T2 prolongation in the right femoral bone head, synovial fluid retention, and bone joint fissure narrowing. The patient was diagnosed with rapidly destructive coxarthrosis (RDC) and received a total hip arthroplasty. This represents a rare case of RDC as a potential side effect of crizotinib in a patient with ROS1-positive lung adenocarcinoma. MRI should therefore be recommended in patients receiving crizotinib who experience continuing severe hip pain and difficulty in walking. Further investigations are warranted to elucidate the pathogenesis of RDC associated with crizotinib treatment.

Published
2020

9. Rapidly Destructive Coxarthrosis as a Potential Side Effect of Crizotinib in a Patient with ROS1-Positive Lung Adenocarcinoma

Author

Takamori,Shinkichi, Seto,Takashi, Jinnouchi,Mikako, Oba,Taro, Yamaguchi,Masafumi, Takenoyama,Mitsuhiro, Takamori,Shinkichi, Seto,Takashi, Jinnouchi,Mikako, Oba,Taro, Yamaguchi,Masafumi, and Takenoyama,Mitsuhiro

Abstract

Shinkichi Takamori, 1 Takashi Seto, 1 Mikako Jinnouchi, 2 Taro Oba, 1 Masafumi Yamaguchi, 1 Mitsuhiro Takenoyama 1 1Department of Thoracic Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka 811-1395, Japan; 2Department of Radiology, National Hospital Organization Kyushu Cancer Center, Fukuoka 811-1395, JapanCorrespondence: Takashi SetoDepartment of Thoracic Oncology, National Hospital Organization Kyushu Cancer Center, 3-1-1 Notame, Minami-Ku, Fukuoka 811-1395, JapanTel +81 92 541 3231Fax +81 92 551 4585Email setocruise@gmail.comAbstract: A 75-year-old woman was diagnosed with c-ros oncogene 1 (ROS1)-positive lung adenocarcinoma. She was treated with crizotinib 750 mg/day for 4.5 years, with partial tumor response. However, the patient subsequently presented with right hip pain and difficulty in walking. She underwent magnetic resonance imaging (MRI), which detected T2 prolongation in the right femoral bone head, synovial fluid retention, and bone joint fissure narrowing. The patient was diagnosed with rapidly destructive coxarthrosis (RDC) and received a total hip arthroplasty. This represents a rare case of RDC as a potential side effect of crizotinib in a patient with ROS1-positive lung adenocarcinoma. MRI should therefore be recommended in patients receiving crizotinib who experience continuing severe hip pain and difficulty in walking. Further investigations are warranted to elucidate the pathogenesis of RDC associated with crizotinib treatment.Keywords: non-small cell lung cancer, ROS1, crizotinib, rapidly destructive coxarthrosis

Published
2020

11. Rapidly Destructive Coxarthrosis as a Potential Side Effect of Crizotinib in a Patient with -Positive Lung Adenocarcinoma.

Author

Takamori, Shinkichi, Seto, Takashi, Jinnouchi, Mikako, Oba, Taro, Yamaguchi, Masafumi, and Takenoyama, Mitsuhiro

Subjects
DRUG side effects, FEMUR head, CRIZOTINIB, TOTAL hip replacement, FEMUR, IDIOPATHIC femoral necrosis
Abstract

A 75-year-old woman was diagnosed with c-ros oncogene 1 (ROS1)-positive lung adenocarcinoma. She was treated with crizotinib 750 mg/day for 4.5 years, with partial tumor response. However, the patient subsequently presented with right hip pain and difficulty in walking. She underwent magnetic resonance imaging (MRI), which detected T2 prolongation in the right femoral bone head, synovial fluid retention, and bone joint fissure narrowing. The patient was diagnosed with rapidly destructive coxarthrosis (RDC) and received a total hip arthroplasty. This represents a rare case of RDC as a potential side effect of crizotinib in a patient with ROS1-positive lung adenocarcinoma. MRI should therefore be recommended in patients receiving crizotinib who experience continuing severe hip pain and difficulty in walking. Further investigations are warranted to elucidate the pathogenesis of RDC associated with crizotinib treatment. [ABSTRACT FROM AUTHOR]

Published
2020
Full Text
View/download PDF

14. Correlations between Apparent Diffusion Coefficient Values and Prognostic Factors of Breast Cancer

Author

KAMITANI, Takeshi, primary, MATSUO, Yoshio, additional, YABUUCHI, Hidetake, additional, FUJITA, Nobuhiro, additional, NAGAO, Michinobu, additional, JINNOUCHI, Mikako, additional, YONEZAWA, Masato, additional, YAMASAKI, Yuzo, additional, TOKUNAGA, Eriko, additional, KUBO, Makoto, additional, YAMAMOTO, Hidetaka, additional, YOSHIURA, Takashi, additional, and HONDA, Hiroshi, additional

Published
2013
Full Text
View/download PDF

15. Evaluation of chronic ischemic heart disease with myocardial perfusion and regional contraction analysis by contrast-enhanced 256-MSCT

Author

Higuchi, Ko, primary, Nagao, Michinobu, additional, Matsuo, Yoshio, additional, Kamitani, Takeshi, additional, Yonezawa, Masato, additional, Jinnouchi, Mikako, additional, Yamasaki, Yuzo, additional, Abe, Koichiro, additional, Baba, Shingo, additional, Mukai, Yasushi, additional, Higo, Taiki, additional, Sunagawa, Kenji, additional, and Honda, Hiroshi, additional

Published
2012
Full Text
View/download PDF

18. A case of localized amyloidosis in the mediastinum, CT, MRI, and 18F-FDG-PET/CT findings.

Author

Jinnouchi, Mikako, Hatakenaka, Masamitsu, Yabuuchi, Hidetake, Matsuo, Yoshio, Sunami, Shunya, Kamitani, Takeshi, Komori, Masahiro, Kitajima, Yuko, Fujita, Nobuhiro, and Honda, Hiroshi

Subjects
AMYLOIDOSIS, MEDIASTINUM diseases, BIOPSY, MAGNETIC resonance imaging, FLUORINE, POSITRON emission tomography, CASE studies, DIAGNOSIS
Abstract

Abstract: Amyloidosis is a heterogeneous group of diseases characterized by the presence of extracellular deposition of amyloid. We present a case of localized amyloidosis of the middle mediastinum, that was diagnosed by trans-esophageal endoscopic ultrasound (EUS)-guided biopsy, focusing on imaging features of contrast-enhanced CT, MRI including dynamic contrast-enhanced study and DWI, and integrated fluorine-18 fluorodeoxyglucose (18F-FDG) positron emission tomography (PET)/CT. [Copyright &y& Elsevier]

Published
2011
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results